CHRISTA LAWHORN: Open Payments
NPI 1083942734 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 49 payments from 20 companies in 2025. Trend: 2023 $413 · 2024 $658 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $216 |
| Lilly USA, LLC | 7 | $164 |
| Novo Nordisk Inc | 9 | $145 |
| AstraZeneca Pharmaceuticals LP | 4 | $140 |
| ABBVIE INC. | 3 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| ACADIA Pharmaceuticals Inc | 1 | $33 |
| Ardelyx, Inc. | 1 | $30 |
Products named: XIFAXAN, MOUNJARO, Wegovy, AIRSUPRA, Kerendia, UBRELVY, Rybelsus, REXULTI.
Industry payments across CA — which companies pay providers there.
